Dichotomy of hyperdiploid acute lymphoblastic leukemia on the basis of the distribution of gained chromosomes

Cancer Genetics and Cytogenetics
F MertensF Mitelman

Abstract

From literature data on 3,149 cytogenetically abnormal cases of acute lymphoblastic leukemia (ALL) 1,118 clones with a gain of 1-11 chromosomes were retrieved. Within each subgroup of polysomy, the distribution of gained chromosomes was clearly nonrandom. In general, two different patterns were seen in ALLs with 1-5 and 6-11 extra chromosomes, respectively. In the former group, chromosomes X, 8, and 21 were consistently over-represented, and in the latter most or all polysomy subgroups contained an excess of chromosomes X, 4, 6, 10, 14, 17, 18, and 21. Chromosomes Y, 1-3, 5, 7, 9, 11-13, 15, 16, 19, and 20 were never significantly over-represented in any polysomy subgroup. The results of the present study confirm the nonrandom nature of chromosomal gain in ALL and suggest that when ALLs are to be subdivided into those with moderate and pronounced hyperdiploidy, the former should contain cases with 47-51 chromosomes and the latter those with 52-57 chromosomes.

References

Oct 1, 1990·Cancer Genetics and Cytogenetics·L M Secker-Walker
Mar 1, 1995·Cancer Genetics and Cytogenetics·A L HartleyA M Kelsey

❮ Previous
Next ❯

Citations

Jul 30, 2003·Cancer Genetics and Cytogenetics·Yesim YilmazMazin B Qumsiyeh
Jul 21, 2001·Cancer Genetics and Cytogenetics·T OdagakiK Saigo
Mar 10, 2001·Genes, Chromosomes & Cancer·H ElghezalS P Romana
Apr 29, 1999·Medical and Pediatric Oncology·K HeinonenM Perkkiö
Nov 26, 2002·Veterinary Clinical Pathology·Peter J FernandesKenneth R Pierce
Apr 26, 2003·Virchows Archiv : an International Journal of Pathology·Laurence de LevalChristian Herens
Aug 24, 2021·Frontiers in Cell and Developmental Biology·Oskar A Haas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.